Trial Summary
What is the purpose of this trial?
This trial tests a program to help people with HIV who don't have enough food. It aims to improve their blood sugar levels by ensuring they have enough to eat. The goal is to reduce the risk of diabetes and related health issues.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment weCare/Secure for addressing food insecurity in people living with HIV?
Research shows that food insecurity affects up to 50% of people living with HIV in the US, leading to lower medication adherence and increased risk of serious illnesses. The weCare/Secure intervention aims to reduce these risks by using a bilingual peer navigation and mobile health approach, which is being tested for its effectiveness in improving health outcomes for food-insecure individuals with HIV.12345
Is the bilingual intervention for HIV/AIDS-related food insecurity safe for humans?
How is the treatment weCare/Secure different from other treatments for HIV/AIDS-related food insecurity?
The weCare/Secure treatment is unique because it combines bilingual peer navigation with mobile health (mHealth) technology to address food insecurity and related health issues in people living with HIV. This approach is novel as it specifically targets the link between food insecurity and cardiometabolic health, using personalized support and technology to improve health outcomes.12479
Research Team
Scott D Rhodes, PhD
Principal Investigator
Wake Forest Health Sciences
Eligibility Criteria
This trial is for adults over 18 with HIV who are patients at the Wake Forest Infectious Diseases Specialty Clinic. They must understand English or Spanish and be able to give informed consent. People with cognitive impairments that prevent participation cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation and evaluation of the weCare/Secure intervention designed to improve insulin sensitivity among food insecure PWH with prediabetes or Type 2 diabetes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Usual Care (Other)
- weCare/Secure (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University
National Institute of Nursing Research (NINR)
Collaborator
Dr. Jessica Gill
National Institute of Nursing Research (NINR)
Chief Medical Officer since 2023
PhD in Nursing from Johns Hopkins University
Dr. Shannon Zenk
National Institute of Nursing Research (NINR)
Chief Executive Officer since 2020
PhD in Urban Planning and Policy Development from Rutgers University
University of North Carolina, Greensboro
Collaborator